NCT06595251 Community Park-Based Programs for Health Promotion: Fit2Play Prospective Cohort Study
| NCT ID | NCT06595251 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Duke University |
| Condition | Overweight |
| Study Type | OBSERVATIONAL |
| Enrollment | 5,000 participants |
| Start Date | 2020-05-07 |
| Primary Completion | 2027-05-17 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 5,000 participants in total. It began in 2020-05-07 with a primary completion date of 2027-05-17.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The Fit2Play prospective cohort study examines the effects of a park-based youth physical activity afterschool program on youth participant fitness and mental health outcomes. Duke will perform a secondary analysis of the data collected as part of the Fit2Play prospective cohort study run by Miami-Dade County Parks and Recreation.
Eligibility Criteria
Inclusion Criteria: * All participants enrolled in the Miami-Dade Fit2Play study will be included in this secondary analysis Exclusion Criteria: * Anyone not enrolled in the Miami-Dade Fit2Play study will be excluded from this secondary analysis
Contact & Investigator
Emily D'Agostino, DPH, MS, MEd, MA
PRINCIPAL INVESTIGATOR
Duke University
Frequently Asked Questions
Who can join the NCT06595251 clinical trial?
This trial is open to participants of all sexes, aged 6 Years or older, up to 14 Years, studying Overweight. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06595251 currently recruiting?
Yes, NCT06595251 is actively recruiting participants. Contact the research team at emily.m.dagostino@duke.edu for enrollment information.
Where is the NCT06595251 trial being conducted?
This trial is being conducted at Miami, United States.
Who is sponsoring the NCT06595251 clinical trial?
NCT06595251 is sponsored by Duke University. The principal investigator is Emily D'Agostino, DPH, MS, MEd, MA at Duke University. The trial plans to enroll 5,000 participants.